期刊文献+

血液透析与多种药物联合治疗慢性肾功能衰竭并发高血压的临床疗效观察 被引量:2

原文传递
导出
摘要 目的探讨血液透析与多种药物联合治疗慢性肾功能衰竭并发高血压的临床疗效。方法选取2013年1月-2015年1月在大连医科大学附属第一医院肾内科接受血液透析治疗后合并高血压的98例慢性肾功能衰竭病人,随机分为对照组和研究组,两组均给予缬沙坦和乌拉地尔治疗,对照组同时联合非洛地平治疗,研究组给予马来酸左旋氨氯地平联合治疗,对比两组的治疗效果。结果治疗后研究组的收缩压、舒张压、心率及血清肌酐水平明显低于对照组,差异具有统计学意义(P〈0.05);治疗2个月后,研究组的血清白蛋白、血红蛋白、血钙水平明显高于对照组,而血磷水平明显低于对照组,差异均具有统计学意义(P〈0.05);治疗2个月后,研究组总有效率高达96.15%,明显高于对照组的82.61%,差异具有统计学意义(P〈0.05)。结论慢性肾功能衰竭在维持性血液透析合并高血压的治疗中,缬沙坦胶囊、拉地尔缓释片联合马来酸左旋氨氯地平片相比于联合非洛地平缓释片,降压效果更好,值得推广应用。
出处 《中国实用乡村医生杂志》 2016年第7期69-71,共3页 Chinese Practical Journal of Rural Doctor
  • 相关文献

参考文献9

  • 1Gluhovschi G, Velciov S, Petrica L, et al. Aspects of renal-pulmonary pathogenic replationships in chronic kidney disease and chronic pulmonary diseases a less- known connection[J]. Rom J Intern Med, 2014, 52(2): 68-77.
  • 2陈辉乐,徐昌隆,金领微,周志宏.老年肾衰竭患者血液透析感染的危险因素分析[J].中华医院感染学杂志,2014,24(4):911-913. 被引量:45
  • 3刘雪波,梁立义.慢性肾衰透析患者并发高血压的药物治疗体会[J].中国保健营养(下半月),2012,0(5):1323-1324. 被引量:1
  • 4Vethe H, Finne K, Skogstrand T, et al. Distinct protein signature of hypertension-induced damage in the renal proteome of the two-kidney, one-clip rat model[J]. J Hypertens, 2015, 33(1): 126-135.
  • 5Muntner P, Davis BR, Cushman WC, et al. Treatment- resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack TriaI(ALLHAT)[J]. Hypertension, 2014, 64(5): 1012-1021.
  • 6马国荣,阿胜,陆蕾,陈孟华.维持性血液透析患者高血压的治疗效果分析[J].宁夏医学杂志,2006,28(6):450-451. 被引量:2
  • 7Guessous I, McClellan W, Kleinbaum D, et al. Comparisons of serum vitamin D levels, status, and determinants in populations with and without chronic kidney disease not requiring renal dialysis: a 24-hour urine collection population-based study[J]. J Ren Nutr, 2014, 24(5): 303-312.
  • 8Sim JJ, Shi J, Kovesdy CP, et al. Impact of achieved blood pressures on mortality risk and end-stage renal disease among a large, diverse hypertension population[J]. J Am Coil Cardiol, 2014, 64(6): 588-597.
  • 9Hassan M, Qureshi W, Sroujieh LS, et al. Interplay of parathyroid hormone and aldosterone antagonist in prevention of heart failure hospitalizations in chronic kidney disease[J]. J Renin Angiotensin Aldosterone Syst, 2014, 15(3): 278-285.

二级参考文献16

  • 1林善琰.当代肾脏病学[M].上海科技教育出版社,2001.198.
  • 2HEMO Study Group(Prepared by Daugirads JT,etal)Methods of estimating the equilibrated Kt/V:date from HEMO Study[J].Kidney Int,1997,52:1395.
  • 3European Best Practice Guideline for Section I] Hemodialysis adeguaey[J]. Nephml Dial Transplant, 2002,17 : 16.
  • 4Bloembergen WE, Port FK. Epidemiological perspective on infections in chronic dialysis patients[J]. Adv Ren Replace Ther, 1996,3(3) .. 201-207.
  • 5Mailloux LU,Bellucci AG,Wilkes BM,et al. Mortality in di- alysis patients: analysis of the causes of death[J]. Am J Kid- ney Dis, 1991,18(3) :326-335.
  • 6Allon M. Ialysis catheter related bacteremia treatment 'and prophylaxis[J]. Am J Kindey Dis,2004,44(5) :779-791.
  • 7Paniagua R,Amato D,Vonesh E,et al.Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial[].Journal of the American Society of Nephrology.2002
  • 8Bethesda US.Department of health and human service,Public Health,National institutes of Health[].United States Renal Data System Report.1998
  • 9MP Hrl,M Tepel.Drug therapy for hypertension in hemodialysis patients[].Minerva Medica.2005
  • 10陈香美,张利.透析患者高血压的治疗策略:我们应从何处开始?[J].中国血液净化,2010,9(2):60-62. 被引量:15

共引文献45

同被引文献12

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部